-
Something wrong with this record ?
Evaluation of a DGP point-of-care test for celiac disease in a pediatric population
Claude-Olivier Marti, Benoit Fellay, Annemarie Bürgin-Wolff, Jean-Luc Magnin, Peter Baehler
Language English Country United States
- Keywords
- point-of-care test, detekce protilátek proti deamidovaným gliadin peptidům, pravidlo-out CD, rychlý test,
- MeSH
- Diet, Gluten-Free MeSH
- Biopsy MeSH
- Celiac Disease * diagnosis immunology complications prevention & control MeSH
- Diagnostic Techniques and Procedures * MeSH
- Child MeSH
- Data Interpretation, Statistical MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Predictive Value of Tests MeSH
- Child, Preschool MeSH
- Retrospective Studies MeSH
- Sensitivity and Specificity * MeSH
- Serologic Tests MeSH
- Statistics as Topic methods standards organization & administration MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
Celiac disease (CD) is a largely undiagnosed immune-mediated enteropathy. A point-of-care test (POCT) could represent a rapid and cost-effective tool on ruling out CD. The objective of this study is to evaluate retrospectively the performance of a POCT based on detection of IgA and IgG antibodies against deamidated gliadins peptides (DGP). The study was performed on 53 children presenting clinical suspicions of CD, all being investigated by intestinal biopsy and standard serology. The performance of POCT was compared to the diagnostic result obtained from the gold standard of histology and serology. 10 children were diagnosed as CD positive by the POCT. Among the 43 children identified as CD negatives, 37 were correctly identified by POCT and 6 were considered as false positives. No false negative results were observed. The POCT yields a sensitivity and a negative predictive value (NPV) of 100%, and a negative likelihood ratio (LR-) of 0 in this selected pediatric population. The high NPV and low LR- ratio indicate that this POCT could be an useful and discriminative tool for excluding CD. This study and the results published so far are promising but need to be confirmed in larger cohort.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15025350
- 003
- CZ-PrNML
- 005
- 20151122233544.0
- 007
- ta
- 008
- 150727s2015 xxua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.12691/ijcd-3-1-8 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Marti, Claude-Olivier $u Hôpital Cantonal Fribourg, Fribourg, Switzerland; Laboratoire Promed, Marly Switzerland
- 245 10
- $a Evaluation of a DGP point-of-care test for celiac disease in a pediatric population / $c Claude-Olivier Marti, Benoit Fellay, Annemarie Bürgin-Wolff, Jean-Luc Magnin, Peter Baehler
- 504 __
- $a Literatura
- 520 9_
- $a Celiac disease (CD) is a largely undiagnosed immune-mediated enteropathy. A point-of-care test (POCT) could represent a rapid and cost-effective tool on ruling out CD. The objective of this study is to evaluate retrospectively the performance of a POCT based on detection of IgA and IgG antibodies against deamidated gliadins peptides (DGP). The study was performed on 53 children presenting clinical suspicions of CD, all being investigated by intestinal biopsy and standard serology. The performance of POCT was compared to the diagnostic result obtained from the gold standard of histology and serology. 10 children were diagnosed as CD positive by the POCT. Among the 43 children identified as CD negatives, 37 were correctly identified by POCT and 6 were considered as false positives. No false negative results were observed. The POCT yields a sensitivity and a negative predictive value (NPV) of 100%, and a negative likelihood ratio (LR-) of 0 in this selected pediatric population. The high NPV and low LR- ratio indicate that this POCT could be an useful and discriminative tool for excluding CD. This study and the results published so far are promising but need to be confirmed in larger cohort.
- 650 12
- $a celiakie $x diagnóza $x imunologie $x komplikace $x prevence a kontrola $7 D002446
- 650 _2
- $a bezlepková dieta $7 D055050
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a sérologické testy $7 D012698
- 650 12
- $a diagnostické techniky a postupy $7 D019937
- 650 12
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a interpretace statistických dat $7 D003627
- 650 _2
- $a statistika jako téma $x metody $x normy $x organizace a řízení $7 D013223
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 653 00
- $a point-of-care test
- 653 00
- $a detekce protilátek proti deamidovaným gliadin peptidům
- 653 00
- $a pravidlo-out CD
- 653 00
- $a rychlý test
- 700 1_
- $a Fellay, Benoit $u Hôpital Cantonal Fribourg, Fribourg, Switzerland
- 700 1_
- $a Bürgin-Wolff, Annemarie $u Coeliakie Institut, Liestal, Switzerland
- 700 1_
- $a Magnin, Jean-Luc $u Hôpital Cantonal Fribourg, Fribourg, Switzerland
- 700 1_
- $a Baehler, Peter $u Hôpital Cantonal Fribourg, Fribourg, Switzerland
- 773 0_
- $t International journal of celiac disease $x 2334-3427 $g Roč. 3, č. 1 (2015), s. 7-11 $w MED00186448
- 856 41
- $u http://www.sciepub.com/journal/index.aspx?id=ijcd $y domovská stránka časopisu
- 910 __
- $a ABA008 $b B 2748 $c 280 $y 4 $z 0
- 990 __
- $a 20150723102837 $b ABA008
- 991 __
- $a 20151122233611 $b ABA008
- 999 __
- $a ok $b bmc $g 1085557 $s 908356
- BAS __
- $a 3
- BMC __
- $a 2015 $b 3 $c 1 $d 7-11 $i 2334-3427 $m International journal of celiac disease $x MED00186448
- LZP __
- $c NLK185 $d 20151122 $a NLK 2015-19/mk